INTERRELATIONSHIP OF CARDIOMETABOLIC RISK FACTORS AND SYMPATHOADRENAL DYSREGULATION IN YOUNG PATIENTS WITH NEW-ONSET ANGINA PECTORIS

Authors

  • Isakov Fakhriddin Yusufjon ugli Department of Faculty Therapy, Andijan State Medical Institute, Andijan, Uzbekistan. Author
  • Vahobov Bahromjon Muminjanovich Department of Faculty Therapy, Andijan State Medical Institute, Andijan, Uzbekistan. Author

Keywords:

hyperactivation, cardiometabolic, sympathoadrenal, pronounced, catecholamine

Abstract

 Premature coronary artery disease (CAD), initially manifesting as new-onset angina pectoris in young adults, represents an escalating clinical challenge. Chronic hyperactivation of the sympathoadrenal system (SAS) combined with metabolic derangements accelerates endothelial injury and coronary plaque instability. In modern clinical cardiology, increasing attention is directed toward subclinical neuroendocrine disturbances as independent predictors of coronary hemodynamic destabilization. Subtle variations in neurohumoral balance can trigger atherogenic dyslipidemia, exacerbate arterial stiffness, and accelerate coronary plaque progression. The exact mechanisms linking SAS functional status with specific cardiometabolic clusters require further clarification to improve prognostic stratification.

References

1.Virani S.S., Newby L.K., Arnold S.V., et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease. Circulation. 2023; 148(9): e9–e119.

2.Sagris M., Antonopoulos A.S., Theofilis P., et al. Risk factors profile of young and older patients with myocardial infarction. Cardiovascular Research. 2022; 118(10): 2281–2292.

3.Collet J.P., Zeitouni M., Procopi N., et al. Long-Term Evolution of Premature Coronary Artery Disease. Journal of the American College of Cardiology. 2019; 74(15): 1868–1878.

4.Grassi G., Mark A., Esler M. The sympathetic nervous system alterations in human hypertension. Circulation Research. 2015; 116(6): 976–990.

5.Lambert E.A., Straznicky N.E., Dixon J.B., Lambert G.W. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? American Journal of Physiology-Heart and Circulatory Physiology. 2015; 309(2): H244–H258.

Downloads

Published

2026-11-15